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The vagus nerve plays a central role in the regulation of gastric acid secretion
and gastrin release. The current understanding of the mechanisms involved in
vagal regulation of acid secretion and gastrin release is reviewed. Thyrotropin-
releasing hormone from the medullary raphe nuclei appears to be the central
excitatory mediator of vagal action in the dorsal motor nucleus. Vagal stimula-
tion of the parietal cell occurs through M3 cholinergic receptors and via the
release of histamine and gastrin from enterochromaffin-like cells and G-cells,
respectively. Somatostatin exerts a tonic basal inhibition of both the parietal
cell and the G-cell. Vagal stimulation suppresses somatostatin release from
delta cells, thereby "disinhibiting" these cells.
INTRODUCTION
The vagus nerves play a central role in the regulation of gastric acid secretion and
gastrin release. The cornerstone of modem surgery for peptic ulcer disease is vagotomy.
Lester Dragstedt, more than any other surgeon, understood both the physiologic and sur-
gical significance of the vagus. Indeed, the introduction of vagotomy in the treatment of
peptic ulcer by Dragstedt in 1943 [1] provided the major impetus for the vigorous explo-
ration in the last 50 years of vagal mechanisms that regulate motor and secretory func-
tions ofthe upper gastrointestinal tract.
Recent advances in immunocytochemistry have defined the nature of the neurons in
the vagus and in the enteric nervous system (ENS)b as well as the structure of the
endocrine cells in the stomach. The advances in cell and molecular biology have
improved significantly our understanding of the regulation of acid secretion and gastrin
release and the role of the vagus in these processes. The importance of the parietal cell
and the antral G-cell has long been understood. In the last 15 years, the crucial role of
somatostatin in modulating both parietal cell and G-cell functions has been established.
More recently, the enterochromaffin-like (ECL) cell has emerged as an important cell in
the oxyntic mucosa in the regulation ofacid secretion. The ECL cell releases histamine in
response to vagal stimulation and to gastrin, thus mediating, at least in part, the action of
the vagus and gastrin on acid secretion.
This paper will review the current understanding of the mechanisms involved in
vagal regulation ofacid secretion and gastrin release.
VAGAL STIMULATION OF ACID SECRETION
Vagal action in acid secretion is important not only in the cephalic phase of acid
secretion but also in the gastric phase in which vago-vagal reflexes mediate acid response
aTo whom allcorrespondence shouldbeaddressed: Haile T. Debas, M.D., Deans Office, University
of California, San Francisco, 513 Parnassus Avenue, S-224, San Francisco, CA 94143. Tel: (415)
476-2342; Fax: (415) 476-0689.
bAbbreviations: ENS, enteric nervous system; ECL, enterochromaffin-like; TRH, thyrotropin-
releasing hormone; DMN, dorsal motor nucleus; GRP, gastrin-releasing peptide; VIP, vasoactive
intestinal polypeptide.
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to distention. As much as 50 percent of the maximal acid response to a meal may be due
to the cephalic phase [2]. The precise mechanisms for the central activation of the dorsal
motor nucleus ofthe vagus (DMN) are poorly understood. Better definition ofthe periph-
eral vagal mechanisms has been recently possible due to the availability of specific
inhibitors and better in-vitro preparations.
CENTRAL ACTIVATION OF THE DMN
The cephalic phase of acid secretion is presumed to result from the activation of
medullary nuclei. (Figure 1) Convincing evidence is accumulating that activation of the
DMN is accomplished by the excitatory action of thyrotropin-releasing hormone (TRH)
as well as serotonin containing neurons that project from the raphe pallidus and obscurus
to the DMN [3]. Two experiments give evidence to support the role ofTRH on the DMN:
a) In cats, microinjection of small doses ofTRH into the DMN causes significant stimu-
lation ofacid secretion and contractions ofthe antrum and corpus [4] and b) the injection
of specific TRH antibody into the cerebrospinal fluid inhibits acid secretion in pylorus-
ligated rats [5].
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Figure 1. Thyrotropin-releasing hormone (TRH) appears to be the central excitatory media-
tor of vagal action. Neurons with their cell bodies in the raphe pallidus and obscurus (medullary
raphe nuclei) release TRH in the dorsal motor nucleus leading to vagal action.
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PERIPHERAL MECHANISMS OF VAGAL ACTION
Vagal stimulation of acid secretion within the stomach has at least four components:
a) direct receptor-mediated action of acetylcholine on the parietal cell; b) indirect action
through cholinergic release of histamine from ECL cells; c) removal of tonic inhibition
by somatostatin due to cholinergic suppression of somatostatin release from fundic delta
cells; and d) indirect action through the release of gastrin from antral G-cells via gastrin-
releasing peptide (GRP) neurons.
Direct Vagal Stimulation ofthe Parietal cell [6]
The parietal cell contains M3 receptors for acetylcholine. Vagal stimulation releases
acetylcholine from post-ganglionic cholinergic neurons adjacent to the parietal cell.
When acetylcholine binds to its receptor, phospholipase C activated rise in cytosolic cal-
cium results in the elaboration of H+/K+-ATPase in the parietal cell, and secretion of H+.
IndirectAction through the Release ofHistamine
Recent studies have shown that vagal stimulation and the administration of choliner-
gic agents release histamine from ECL cells [7]. Histamine, of course, is a crucial stimu-
lant of acid secretion through receptor-mediated increase in adenylate cyclase. The extent
to which this histamine pathway is important in vagal stimulation of acid secretion is
unknown. Some have cited the inhibition of vagally-stimulated acid secretion by H2-
receptor antagonists as additional evidence ofthe important role histamine plays in vagal-
ly-mediated acid secretion [8]. However, the inhibitory effect of H2-receptor blockers on
the acid response to vagal stimulation could represent inhibition of post-receptor interac-
tions.
It is now thought that the physiologically relevant pool of histamine that lies within
diffusion distance of the parietal cell is that contained within ECL cells [9]. The ECL
cells make up approximately 65 percent and 35 percent of the entire population of the
endocrine cells ofthe oxyntic mucosa ofthe rat and man, respectively. Unlike mast cells,
which are predominantly located in the lamina propria, ECL cells are rich in histidine
decarboxylase, the enzyme responsible for histamine synthesis. Recently, the vagus nerve
has been shown to exert a regulatory influence on the metabolism of histamine in the
human oxyntic mucosa [10].
VagalAction on Somatostatin Release
The prime paracrine inhibitor of acid secretion is somatostatin. Somatostatin exerts
tonic inhibition of acid secretion from the parietal cell through G-protein coupled recep-
tors that suppress adenylate cyclase activity [11]. Acetylcholine released from postgan-
glionic, cholinergic vagal nerve endings in the oxyntic mucosa inhibits the release of
somatostatin from delta cells. The decrease in somatostatin in the interstitial fluid sur-
rounding the parietal cells, results in the "disinhibition" of this cell, which then becomes
more sensitive to stimulation by histamine, acetylcholine and gastrin [11]. The inhibitory
regulation of somatostatin on the basal function of the parietal cell has been assessed by
the administration ofhighly specific monoclonal antibodies to somatostatin. The result is
70 percent augmentation of acid secretion [12]. The delta cell also regulates parietal cell
function indirectly through its influence on the ECL cell. Somatostatin inhibits histamine
release and acid secretion in isolated rabbit gastric glands [12].
IndirectAction through the Release ofGastrin
Vagal stimulation releases gastrin by activating GRP neurons and by suppressing
somatostatin release from antral deltacells, thus eliminating the inhibitory action ofthis
147Debas and Carvajal: Vagus on acid and gastrin secretion
peptide [13]. The contribution of gastrin to the cephalic phase of acid secretion is uncer-
tain. In a study of antral vagotomy in dogs, Hirschowitz and Fong suggest that the contri-
bution ofgastrin is small and that vagal stimulation of acid secretion occurs almost exclu-
sively through its fundic pathways [14].
VAGAL STIMULATION OF GASTRIN RELEASE
Vagal stimulation ofgastrin release has two components: a) GRP-mediated release of
the peptide and b) inhibition of somatostatin release from antral delta cells, thereby
removing the inhibitory control of somatostatin on the G-cells. GRP, the mammalian ana-
log of the amphibian peptide bombesin, is released from peptidergic, post-ganglionic,
parasympathetic, intramural vagal fibers and neurons of the ENS [15]. Gastrin release in
response to electrical vagal stimulation is inhibited by bombesin antagonists, indicating
the importance of GRP as the mediator of vagal release of gastrin [16]. Somatostatin
exerts tonic inhibitory regulation of gastrin secretion. Both muscarinic agonists and
immunoneutralization of gastric somatostatin with monoclonal antibodies to somatostatin
cause a two- to three-fold increase in gastrin release [17, 18]. Electrical vagal stimulation
results in decreased secretion of somatostatin from the vascularly perfused stomach [19].
The physiologic contribution of gastrin during the cephalic phase of acid secretion is
unclear. In man, dog and rat, gastrin mediates a portion of acid secretion during the
cephalic phase. In dogs, approximately 70 percent of acid secretion induced by insulin
hypoglycemia was blocked by the administration of a gastrin monoclonal antibody [20].
In humans, a small but significant rise in plasma levels of gastrin is seen during sham-
feeding [21]. Small doses of atropine enhance gastrin response to sham-feeding, presum-
ably by blocking the vagal effect on somatostatin release [22].
VAGAL INHIBITORY MECHANISMS
Activation of the vagus invariably results in stimulation of acid secretion. As dis-
cussed earlier, this response is mediated in part through the inhibitory effect of the vagus
on somatostatin release. Several inhibitory peptidergic pathways are activated by vagal
stimulation. These include vasoactive intestinal polypeptide (VIP), neuropeptide Y, calci-
tonin gene-related peptide, substance P and galanin. To what extent these neural path-
ways exert inhibitory control of acid secretion is unknown. For example, vagal action
releases VIP from the ENS of the fundus to mediate muscular relaxation. VIP also releas-
es somatostatin in the fundus. Whether this action is physiologically significant in acid
secretion is unknown [23].
If the inhibitory vagal regulation of the oxyntic cell is not clear, the evidence for
inhibitory regulation of the G-cell is strong. Indeed, with respect to gastrin release, the
inhibitory role of the vagus appears more significant than its stimulatory action.
Following all types of vagotomy, basal and post-prandial hypergastrinemia develops [24].
There appears to be a tonic vagal inhibitory mechanism that is removed by vagotomy
[25]. Furthermore, the vagal fibers that stimulate gastrin release appear to be those dis-
tributed to the antrum through the nerves ofLatarjet. Division ofthese antral nerves abol-
ishes vagally-stimulated gastrin release [14]. On the other hand, interruption of the vagal
supply to the proximal stomach, as in highly selective or parietal cell vagotomy, leads to
hypergastrinemia. Undoubtedly, one cause ofthe hypergastrinemia is reduction in luminal
acid. However, post-vagotomy hypergastrinemia is not totally explainable on this basis.
The mediation of this acid-independent mechanism of inhibition of gastrin release by
fundic vagal pathways is not yet elucidated.
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EFFECT OF VAGOTOMY ON ACID SECRETION AND GASTRIN RELEASE
Vagotomy results in 85 percent and 50-60 percent inhibition of basal and post-pran-
dial acid secretion, respectively. Vagotomy also results in significant inhibition of pepsin
secretion. The rationale for vagotomy in the treatment ofpeptic ulcer disease is based on
these observations. These effects are largely mediated by the fall of acetylcholine release
within the gastric wall. Vagotomy also has known effects on the two other primary stimu-
lants ofacid secretion, histamine and gastrin. (Figure 2).
Vagus Nerve
Gastrin
Figure 2. The known interactions of the vagus affecting acid secretion and gastrin release is
illustrated (GRP, gastrin-releasing peptide; ACh, acetylcholine). Vagal stimulation of the pari-
etal cell occurs through M3 cholinergic receptors and via the release of histamine and gastrin from
enterochromaffin-like (ECL) cells and G-cells, respectively. Somatostatin (SS) exerts a tonic basal
inhibition ofboth the parietal cell and the G-cell. Vagal stimulation suppresses somatostatin release
from delta cells, thereby "disinhibiting" these cells.
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Following proximal gastric vagotomy in patients with duodenal ulcer, histamine con-
tent in the oxyntic mucosa rises without a concomitant increase in histidine decarboxy-
lase activity [10]. However, the ability ofpentagastrin to induce new histamine formation
is impaired. It has been suggested that the clinical effect of vagotomy may be partly due
to the reduction in the amounts of endogenous histamine synthesized and released in
response to various stimuli [10].
Both basal and post-prandial hypergastrinemia follow vagotomy. This hypergastrine-
mia is rarely higher than two to three times the pre-vagotomy level. The cause of post-
vagotomy hypergastrinemia is three-fold: a) Withdrawal of the vagus-dependent fundic
inhibitory mechanism; b) decrease in luminal acid, resulting in the decrease of somato-
statin-dependent negative feed-back regulation; and c) G-cell hyperplasia.
CONCLUSION
The vagus plays an important physiologic role on the regulation of acid secretion,
gastrin release, and histamine production. Despite many recent advances in the under-
standing of these interactions, further research is needed to understand the following
questions: what are the mediators of the dorsal motor nucleus? What is the contribution
of vagally-mediated histamine release on acid secretion? By what mechanism does H2-
receptor antagonists inhibit acid response to vagal stimulation? In conjunction with
somatostatin, what other neuropeptides inhibit acid secretion? What is the mechanism of
vagal inhibition on gastrin release? These questions will certainly be answered in the near
future further advancing our understanding ofvagally-mediated acid secretion.
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